ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 160 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | -83.3% | 1,500 | -87.6% | 0.00% | – |
| Q3 2020 | $6,000 | -71.4% | 12,088 | -57.6% | 0.00% | – |
| Q2 2020 | $21,000 | -30.0% | 28,524 | -13.1% | 0.00% | – |
| Q1 2020 | $30,000 | +200.0% | 32,826 | +571.7% | 0.00% | – |
| Q4 2019 | $10,000 | 0.0% | 4,887 | +39.8% | 0.00% | – |
| Q3 2019 | $10,000 | -52.4% | 3,496 | +27.7% | 0.00% | – |
| Q2 2019 | $21,000 | -44.7% | 2,738 | -4.8% | 0.00% | – |
| Q1 2019 | $38,000 | -13.6% | 2,876 | -0.1% | 0.00% | – |
| Q4 2018 | $44,000 | +46.7% | 2,879 | +89.7% | 0.00% | – |
| Q3 2018 | $30,000 | +172.7% | 1,518 | +290.2% | 0.00% | – |
| Q2 2018 | $11,000 | +22.2% | 389 | -0.8% | 0.00% | – |
| Q1 2018 | $9,000 | -64.0% | 392 | -66.5% | 0.00% | – |
| Q4 2017 | $25,000 | -79.5% | 1,169 | -77.4% | 0.00% | – |
| Q3 2017 | $122,000 | -36.1% | 5,164 | -46.8% | 0.00% | – |
| Q2 2017 | $191,000 | -32.0% | 9,712 | -27.5% | 0.00% | – |
| Q1 2017 | $281,000 | +420.4% | 13,388 | +368.9% | 0.00% | – |
| Q4 2016 | $54,000 | -97.5% | 2,855 | -97.2% | 0.00% | -100.0% |
| Q3 2016 | $2,135,000 | -18.4% | 102,264 | -0.4% | 0.00% | -50.0% |
| Q2 2016 | $2,618,000 | -4.3% | 102,630 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $2,737,000 | -41.2% | 103,465 | -5.0% | 0.00% | -33.3% |
| Q4 2015 | $4,657,000 | +3596.0% | 108,867 | +2199.7% | 0.00% | – |
| Q3 2015 | $126,000 | -73.5% | 4,734 | -66.9% | 0.00% | – |
| Q2 2015 | $476,000 | +29.0% | 14,294 | +28.8% | 0.00% | – |
| Q1 2015 | $369,000 | -71.5% | 11,101 | -65.0% | 0.00% | -100.0% |
| Q4 2014 | $1,297,000 | +2216.1% | 31,745 | +1796.4% | 0.00% | – |
| Q3 2014 | $56,000 | +1300.0% | 1,674 | +1158.6% | 0.00% | – |
| Q2 2014 | $4,000 | -99.6% | 133 | -99.4% | 0.00% | -100.0% |
| Q1 2014 | $903,000 | +22475.0% | 23,817 | +15070.1% | 0.00% | – |
| Q4 2013 | $4,000 | -55.6% | 157 | -35.7% | 0.00% | – |
| Q3 2013 | $9,000 | -30.8% | 244 | -33.7% | 0.00% | – |
| Q2 2013 | $13,000 | – | 368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |